153 related articles for article (PubMed ID: 21800341)
1. Critical illness evokes elevated circulating bile acids related to altered hepatic transporter and nuclear receptor expression.
Vanwijngaerden YM; Wauters J; Langouche L; Vander Perre S; Liddle C; Coulter S; Vanderborght S; Roskams T; Wilmer A; Van den Berghe G; Mesotten D
Hepatology; 2011 Nov; 54(5):1741-52. PubMed ID: 21800341
[TBL] [Abstract][Full Text] [Related]
2. Alteration of Bile Acid and Cholesterol Biosynthesis and Transport by Perfluorononanoic Acid (PFNA) in Mice.
Zhang Y; Zhang Y; Klaassen CD; Cheng X
Toxicol Sci; 2018 Mar; 162(1):225-233. PubMed ID: 29112762
[TBL] [Abstract][Full Text] [Related]
3. Effects of Yinzhihuang on Alleviating Cyclosporine A-Induced Cholestatic Liver Injury via Farnesoid X Receptor-Mediated Regulation of Transporters and Enzymes in Vitro and in Vivo.
Qin Y; Tan J; Han X; Wang N; Zhai X; Lu Y
Biol Pharm Bull; 2023; 46(12):1810-1819. PubMed ID: 38044100
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the renal apical sodium dependent bile acid transporter prevents cholemic nephropathy in mice with obstructive cholestasis.
Ghallab A; González D; Strängberg E; Hofmann U; Myllys M; Hassan R; Hobloss Z; Brackhagen L; Begher-Tibbe B; Duda JC; Drenda C; Kappenberg F; Reinders J; Friebel A; Vucur M; Turajski M; Seddek AL; Abbas T; Abdelmageed N; Morad SAF; Morad W; Hamdy A; Albrecht W; Kittana N; Assali M; Vartak N; van Thriel C; Sous A; Nell P; Villar-Fernandez M; Cadenas C; Genc E; Marchan R; Luedde T; Åkerblad P; Mattsson J; Marschall HU; Hoehme S; Stirnimann G; Schwab M; Boor P; Amann K; Schmitz J; Bräsen JH; Rahnenführer J; Edlund K; Karpen SJ; Simbrunner B; Reiberger T; Mandorfer M; Trauner M; Dawson PA; Lindström E; Hengstler JG
J Hepatol; 2024 Feb; 80(2):268-281. PubMed ID: 37939855
[TBL] [Abstract][Full Text] [Related]
5. CYP7A1 Gene Induction via SHP-Dependent or Independent Mechanisms can Increase the Risk of Drug-Induced Liver Injury Independently or in Synergy with BSEP Inhibition.
Niu C; Xie X; Liu R; Liang X; Hu Y; Lai Y
Drug Metab Dispos; 2024 Apr; 52(5):432-441. PubMed ID: 38485279
[TBL] [Abstract][Full Text] [Related]
6. A homozygous R148W mutation in Semaphorin 7A causes progressive familial intrahepatic cholestasis.
Pan Q; Luo G; Qu J; Chen S; Zhang X; Zhao N; Ding J; Yang H; Li M; Li L; Cheng Y; Li X; Xie Q; Li Q; Zhou X; Zou H; Fan S; Zou L; Liu W; Deng G; Cai SY; Boyer JL; Chai J
EMBO Mol Med; 2021 Nov; 13(11):e14563. PubMed ID: 34585848
[TBL] [Abstract][Full Text] [Related]
7. Fecal bile acid excretion and messenger RNA expression levels of ileal transporters in high risk gallstone patients.
Herrera J; Amigo L; Husche C; Benítez C; Zanlungo S; Lütjohann D; Miquel JF; Nervi F
Lipids Health Dis; 2009 Dec; 8():53. PubMed ID: 19995447
[TBL] [Abstract][Full Text] [Related]
8. Identification of functionally relevant lysine residues that modulate human farnesoid X receptor activation.
Sun AQ; Luo Y; Backos DS; Xu S; Balasubramaniyan N; Reigan P; Suchy FJ
Mol Pharmacol; 2013 May; 83(5):1078-86. PubMed ID: 23462506
[TBL] [Abstract][Full Text] [Related]
9. Pregnane X receptor as a therapeutic target for cholestatic liver injury.
Lan H; Zhang Y; Fan M; Wu B; Wang C
Drug Metab Rev; 2023 Nov; 55(4):371-387. PubMed ID: 37593784
[TBL] [Abstract][Full Text] [Related]
10. Featuring molecular regulation of bile acid homeostasis in pediatric short bowel syndrome.
Mutanen A; Pakarinen MP
Clin Res Hepatol Gastroenterol; 2023 Nov; 47(9):102220. PubMed ID: 37769812
[TBL] [Abstract][Full Text] [Related]
11. In vivo mouse models to study bile acid synthesis and signaling.
Bhattacharya A; Taylor RE; Guo GL
Hepatobiliary Pancreat Dis Int; 2023 Oct; 22(5):466-473. PubMed ID: 37620226
[TBL] [Abstract][Full Text] [Related]
12. An updated review on drug-induced cholestasis: mechanisms and investigation of physicochemical properties and pharmacokinetic parameters.
Yang K; Köck K; Sedykh A; Tropsha A; Brouwer KL
J Pharm Sci; 2013 Sep; 102(9):3037-57. PubMed ID: 23653385
[TBL] [Abstract][Full Text] [Related]
13. Genetic determinants of gut microbiota composition and bile acid profiles in mice.
Kemis JH; Linke V; Barrett KL; Boehm FJ; Traeger LL; Keller MP; Rabaglia ME; Schueler KL; Stapleton DS; Gatti DM; Churchill GA; Amador-Noguez D; Russell JD; Yandell BS; Broman KW; Coon JJ; Attie AD; Rey FE
PLoS Genet; 2019 Aug; 15(8):e1008073. PubMed ID: 31465442
[TBL] [Abstract][Full Text] [Related]
14. Hsp90 and hepatobiliary transformation during sea lamprey metamorphosis.
Chung-Davidson YW; Yeh CY; Bussy U; Li K; Davidson PJ; Nanlohy KG; Brown CT; Whyard S; Li W
BMC Dev Biol; 2015 Dec; 15():47. PubMed ID: 26627605
[TBL] [Abstract][Full Text] [Related]
15. New insights into the bile acid-based regulatory mechanisms and therapeutic perspectives in alcohol-related liver disease.
Liu Y; Liu T; Zhao X; Gao Y
Cell Mol Life Sci; 2022 Aug; 79(9):486. PubMed ID: 35978227
[TBL] [Abstract][Full Text] [Related]
16. Impaired Bile Secretion Promotes Hepatobiliary Injury in Sickle Cell Disease.
Vats R; Liu S; Zhu J; Mukhi D; Tutuncuoglu E; Cardenes N; Singh S; Brzoska T; Kosar K; Bamne M; Jonassaint J; Adebayo Michael A; Watkins SC; Hillery C; Ma X; Nejak-Bowen K; Rojas M; Gladwin MT; Kato GJ; Ramakrishnan S; Sundd P; Monga SP; Pradhan-Sundd T
Hepatology; 2020 Dec; 72(6):2165-2181. PubMed ID: 32190913
[TBL] [Abstract][Full Text] [Related]
17. Melatonin alleviates necrotizing enterocolitis by reducing bile acid levels through the SIRT1/FXR signalling axis.
Lai J; Li F; Li H; Huang R; Ma F; Gu X; Cai Y; Huang D; Li S; Xiao S; Hao H
Int Immunopharmacol; 2024 Feb; 128():111360. PubMed ID: 38176339
[TBL] [Abstract][Full Text] [Related]
18. Rapid in vivo evaluation system for cholestasis-related genes in mice with humanized bile acid profiles.
Wakasa K; Tamura R; Osaka S; Takei H; Asai A; Nittono H; Kusuhara H; Hayashi H
Hepatol Commun; 2024 Apr; 8(4):. PubMed ID: 38517206
[TBL] [Abstract][Full Text] [Related]
19. Nuclear receptors: mediators and modifiers of inflammation-induced cholestasis.
Mulder J; Karpen SJ; Tietge UJ; Kuipers F
Front Biosci (Landmark Ed); 2009 Jan; 14(7):2599-630. PubMed ID: 19273222
[TBL] [Abstract][Full Text] [Related]
20. Cholestatic liver (dys)function during sepsis and other critical illnesses.
Jenniskens M; Langouche L; Vanwijngaerden YM; Mesotten D; Van den Berghe G
Intensive Care Med; 2016 Jan; 42(1):16-27. PubMed ID: 26392257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
